Abstract-We studied the relationship between inhibition of 45Ca2+ uptake and the antinociceptive action induced by morphine and effects of papaverine and 1,1-diphenyl 3-piperidinobutanol hydrochloride (Aspaminol) on both these actions of morphine. Addition of these drugs in the incubation medium significantly inhibited glutamate stimulated synaptosomal 45Ca2+ uptake. The inhibition curves of morphine and Aspaminol on glutamate-stimulated synaptosomal 45Ca2+ uptake were linear, but that of papaverine was not. The inhibition of morphine on synaptosomal 45Ca2+ uptake was reversed by addition of naloxone. The inhibition of synaptosomal 45Ca2+ uptake induced by morphine was increased by the simultaneous addition of Aspaminol, but the inhibition induced by both morphine and papaverine was not increased to more than that by papaverine alone. Since morphine-antinociception was potentiated by Aspaminol and blocked by papaverine, these results support that the inhibition of synaptosomal calcium uptake plays an important role in the production of morphine-antinociception.
Since influx of calcium ions into nerve endings is coupled with exocytotic release of neurotransmitters (1) , movement of calcium ions outside and within neurones is an important determinant in the functioning of nervous systems. It has been reported that some of the central nervous acting drugs such as barbiturates (2, 3) , chlorpromazine (4) and phenytoin (5) block stimuli-induced 45Ca2+ uptake into nerve endings (syn aptosomes). Morphine also inhibited syn aptosomal 45Ca2+ uptake (6) and release of neurotransmitter (7), but findings of Leslie et al. (8) and our previous results (9) indicated that the inhibitory effect of syn aptosomal 45Ca2+ uptake by morphine was very weak, if any. We previously reported that Aspaminol, a nonspecific smooth muscle relaxant, which inhibited uptake of calcium ions into smooth muscle (10) and its micro somal fractions (11, 12) , also inhibited stimuli-induced synaptosomal 45Ca2+ uptake (13). On the other hand, some authors reported that the smooth muscle relaxing effects of papaverine were considered to act through different mechanisms such as in hibition of calcium uptake on the plasma membrane (14) , inhibition of cyclic AMP phosphodiesterase (15) and inhibition of mitochondrial respiration (16) . It is known that synaptosomal fractions take up 45Ca2+ through components such as the synaptic for 10 min at 0°C. The pellets were resuspended in Ca2+-free physiological salt solution to give protein concentrations of about 0.5 to 1.0 mg/ml which were deter mined by the method of Lowry et al. (18) using a bovine serum albumin as the standard, and these suspensions were kept on ice prior to the incubation. The uptake of 45Ca2+ into the preparations was studied as described by a modification of the method of Tan et al. (19) . The pre parations were first preincubated in Ca2}-free physiological salt solution for 5 min at 30°C. The uptake of 45Ca2+ into the preparations was initiated by addition of an equal volume of stimulator solution containing 132 mM NaCI, 5 mM KCI, 1.2 mM NaH2PO4, Sankyo. Aspaminol (1,1 -diphenyl-3-piperi dinobutanol hydrochloride) was from Kowa. Papaverine hydrochloride, L-glutamate and G EDTA (ethyleneglycol bis (Q amino ethylether)-N,N'-tetraacetic acid) was from Wako-Junyaku. Ficoll 400 was from Phar macia Fine Chemicals, and 45CaC12 (specific activity 16 mCi/mg) obtained from New England Nuclear. Other chemicals used were of analytical grade. Drugs were dissolved in double-distilled and deionized water. Results 45Ca2+ uptake: We compared the effect of glutamate on 45Ca2+ uptake into the P2 fraction and myelin, synaptosomal and mito chondrial fractions which were sub fractionated from the P2 fraction using discontinuous Ficoll gradient centrifugation. Figure 1A shows that 45Ca2+ uptake into P2, synaptosomal and mitochondrial fractions are significantly increased by addition of glutamate in the incubation medium as compared to that in the absence of glutamate, while that into the myelin fraction was not. Because mitochondria accumulated 45Ca2+, we further studied effects of sodium azide, a potent mitochondrial inhibitor, on glutamate stimulated 45Ca2+ uptakes into synaptosomal and mitochondrial fractions in the following experiments:
Only 24.6% of the glutamate stimulated 45Ca2+ uptake into synaptosomes could be blocked by sodium azide, but that of mitochondria was markedly depressed (70.1%) ( Fig. 1 B) ; These results were in good agreement with that reported by Delgado Escueta et al. (21) . Figure 2 shows the effect of morphine on glutamate-stimulated synaptosomal 45Ca2+ uptake as a function of time. The synaptosomal 45Ca2+ uptake was rapid within the first 5 min of exposure to glutamate and appeared to approach a plateau phase at 15 min. Morphine (10 -6M) significantly inhibited the glutamate stimulated 45Ca2+ uptake into synaptosomes, while morphine (10-6 M) did not affect the synaptosomal 45Ca2+ uptake in the absence of glutamate (basal uptake). On the other hand, papaverine (10-4 M) and Aspaminol (10-4 M) significantly inhibited the 45Ca2+ uptake into synaptosomes in the presence of glutamate. Both these drugs also signifi cantly inhibited the basal uptake, but their inhibitory effects were less than in the presence of glutamate (Fig. 3) . Morphine slightly but significantly inhibited glutamate stimulated synaptosomal 45Ca2+ uptake in a concentration-dependent manner (Y= -0 .1079X+5.8656, r=-0.5383, P<0.01) while basal uptake was not significantly inhibited by various concentrations (10-8 M to 10-5 M) of morphine (Fig. 4A) . Papaverine (10-6 M to 10-4 M) significantly inhibited glutamate-stimulated synaptosomal 45Ca2+ uptake, and its concentration-dependent curve was not straightened. Papaverine at 10-4 M also inhibited basal uptake (Fig. 4B) . Aspaminol (10-6 M to 10-4 M) significantly inhibited glutamate-stimulated synaptosomal 45Ca2+ uptake in a concentration-dependent manner (Y=-1.2225X-1.6142, r=-0.9280, P<0.01), and basal uptake was less but significantly inhibited by 10-6 M to 10-4 M Aspaminol (Fig. 4C) . The inhibition of glutamate-stimulated synaptosomal 45Ca2+ uptake by 10-6 M morphine was prevented by addition of 10-6 M naloxone with morphine before calcium uptake was initiated, while glutamate-stimulated 45Ca2+ uptake was not influenced by 10-6M naloxone alone (Fig. 5) . Although Aspaminol (5x10-5 M) and papaverine (3x10-5 M) inhibited the basal and glutamate-stimulated 45Ca2+ uptakes Closed marks: in the presence of glutamate.
*, **: significantly different from the corresponding 45Ca2+ uptake in the absence of drugs at P<0.05 and P<0.01, re spectively. into synaptosomes and morphine (10-6 M) inhibited the glutamate-stimulated syn aptosomal 45Ca2+ uptake, the inhibitions of synaptosomal 45Ca2+ uptake induced by morphine (10-6 M) was increased by addition of Aspaminol (5x`10-5 M) but not by papa verine (3x10-5 M) ( Table 1 ).
Assessment
of antinociceptive activity: The maximum effective time of antinocicep tive activity was 30 min for morphine (2.5 mg/kg, s.c.) and papaverine (100 mg/kg, s.c.). With the combined administration of morphine (2.5 mg/kg, s.c.) and papaverine (100 mg/kg, s.c.) at the same time, the maximum effective time was also 30 min, and the antinociceptive activity induced by both the drugs was smaller than that by morphine alone (Fig. 6 ). Therefore, we tested the inhibitory effect of papaverine on morphine-antinociception when morphine (2.5 mg/kg, s.c.) was administered 30 min after pretreatment of the rats with papaverine (100 mg/kg, s.c.). Figure 7 shows s.c.) alone had no effect (Fig. 8) .
Discussion
Several investigators have suggested that inhibition of the influx of calcium ions into the nerve endings plays an important role for the antinociceptive action of morphine (6), and this action was a naloxone reversible processes (6). Our results also showed that morphine inhibited glutamate-stimulated syn aptosomal 45Ca2+ uptake in a concentration dependent manner, but not basal uptake. This inhibition was abolished by addition of naloxone. The inhibitory action of morphine on glutamate-stimulated synaptosomal 45Ca2+ uptake was in agreement with a previous report using depolarizing agents (9) . Aspaminol also inhibited glutamate stimulated synaptosomal 45Ca2+ uptake in a concentration-dependent manner. The in hibition of 45Ca2+ uptake was similar to that of ATP and high KCI stimulated synaptosomal 45Ca2+ uptake as reported previously (13) , but the effect of Aspaminol on basal uptake was different from that in the previous report (13). This discrepancy may be mainly due to a difference in conditions for preincubation with Aspaminol. Papaverine also reduced glutamate-stimulated synaptosomal 45Ca2+ uptake. Several investigators suggested that Ca2+ transport across the synaptosomal membranes was affected by any change in Ca2+-concentration which was controlled by intrasynaptosomal mitochondria (22) . Some authors reported that glutamate in creased 45Ca2+ uptake into synaptic plasma membranes and synaptosomes in the presence of mitochondrial poisons (21) . In these experiments, the effects of drugs on glutamate-stimulated synaptosomal 45Ca2+ uptake were evaluated in the absence of mitochondrial poisons. Therefore, glutamate may act on both plasma membranes and intrasynaptosomal mitochondria. Takagi et al. (23) suggested that weak bases such as papaverine (pKa 5.95) are expected to penetrate into cell membranes at physiological pH and act on intracellular organelles. Papaverine blocks the mitochondrial respira tory chain between NAD and cytochrome b (16) . On the other hand, Takayanagi et al. (14) reported that papaverine also inhibited calcium uptake into the plasma membrane derived vesicles. Therefore, papaverine may act on both synaptosomal plasma membranes and intrasynaptosomal mitochondria. On the other hand, since most of the Aspaminol molecules exist as ion forms at physiological pH (pKa of Aspaminol: 8.62), it may be difficult for these molecules to penetrate into cell membranes and act on the cell surface. As the inhibition of morphine on synaptosomal 45Ca2+ uptake was reversed by addition of naloxone, morphine acts on cell membranes mediated through opiate receptors which are localized on the cell surface (24) . Therefore, the inhibition curves of morphine and Aspaminol on synaptosomal 45Ca2+ uptake may be linear , but that of papaverine is not. The inhibition of syn aptosomal 45Ca2+ uptake induced by mor phine was increased by simultaneous ad dition of Aspaminol, but the inhibition induced by both morphine and papaverine was not increased more than that by papa verine alone. These results may be related to the effects of Aspaminol and papaverine on the antinociceptive action of morphine. While Aspaminol increased morphine antinociception, the antinociceptive activity of morphine was not influenced by simultaneous administration of papaverine, but was blocked by the 30 min pretreatment with papaverine. It may be difficult for Aspaminol to pass through the blood-brain barrier because most of the Aspaminol molecules exist as ion forms at physiological pH, but a small quantity of non-ionized Aspaminol molecules also exist at physiological pH. Harris et al. (25) suggested that the anti nociceptive effect of morphine was poten tiated by intracerebroventricular injection of EGTA, a calcium chelator, and antagonized by simultaneous intracerebroventricular in jection of X537A, a calcium ionophore, and a low dose of calcium, although neither X537A nor this dose of calcium alone blocked the morphine-antinociception. There fore, we considered that a minor change of calcium movement into the nerve endings showed a further extent of morphine antinociception and that Aspaminol may have potentiated the morphine-antinocicep tion by minor inhibition of calcium uptake into synaptosomes, although a sufficient concentration of Aspaminol in the rat brain to induce central actions was not obtained by subcutaneous administration. These results support previous findings that the inhibition of synaptosomal calcium uptake plays an important role for the production of morphine-anti nocicepti on. Papaverine block ed morphine-antinociception, notwithstand ing that 10-4 M papaverine completely inhibited glutamate-stimulated 45Ca2+ uptake into synaptosomes. Therefore, it may be difficult to account for the antinociceptive action of morphine by the inhibition of 45Ca2+ uptake only. An intracerebral or intravenous administration of cyclic AMP to mice antagonized the antinociception of morphine (26) . It is well known that papaverine is a potent inhibitor of phosphodiesterase (15) and that Aspaminol is found to have little inhibitory action on the phosphodiesterase activity in smooth muscle (27) . Inhibition of morphine-antinociception by papaverine may be due to elevation of the cyclic AMP level which is caused by inhibition of phos phodiesterase. 
